BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8808781)

  • 1. Simplex lattice design for the optimization of the microencapsulation of a water soluble drug using poly(lactic acid) and poly(lactide co-glycolide) copolymer.
    Elkheshen S
    J Microencapsul; 1996; 13(4):447-62. PubMed ID: 8808781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
    Elkheshen SA; Radwan MA
    J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(D,L-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system.
    Mandal TK; Bostanian LA; Graves RA; Chapman SR
    Pharm Res; 2002 Nov; 19(11):1713-9. PubMed ID: 12458678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
    Shiga K; Muramatsu N; Kondo T
    J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
    Basarkar A; Devineni D; Palaniappan R; Singh J
    Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
    Pavanetto F; Genta I; Giunchedi P; Conti B
    J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
    Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
    Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
    J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer type.
    Soppimath KS; Aminabhavi TM
    J Microencapsul; 2002; 19(3):281-92. PubMed ID: 12022494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of biodegradable drug delivery system to treat addiction.
    Mandal TK
    Drug Dev Ind Pharm; 1999 Jun; 25(6):773-9. PubMed ID: 10349563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Characterization of PLGA Shell Microcapsules Containing Aqueous Cores Prepared by Internal Phase Separation.
    Abulateefeh SR; Alkilany AM
    AAPS PharmSciTech; 2016 Aug; 17(4):891-7. PubMed ID: 26416284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide).
    Matsumoto A; Matsukawa Y; Suzuki T; Yoshino H
    J Control Release; 2005 Aug; 106(1-2):172-80. PubMed ID: 15936109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of mitomycin-C from poly(DL-lactide) /poly(DL-lactide-co-glycolide) films.
    Gümüşderelioglu M; Deniz G
    J Biomater Sci Polym Ed; 2000; 11(10):1039-50. PubMed ID: 11211156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro performance of carbamazepine loaded to various molecular weights of poly (D,L-lactide-co-glycolide).
    Barakat NS; Radwan MA
    Drug Deliv; 2006; 13(1):9-18. PubMed ID: 16401588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.